Erlotinib Active Not Recruiting Phase 2 Trials for Locally Advanced Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01683175Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation